BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22727541)

  • 1. Multiresistant extended-spectrum β-lactamase producing Escherichia coli in human urine samples in Portugal.
    Pacheco R; Correia S; Monteiro R; Gonçalves A; Radhouani H; Ramos S; Carvalho E; Carvalho J; Igrejas G; Poeta P
    J Microbiol Immunol Infect; 2013 Oct; 46(5):399-404. PubMed ID: 22727541
    [No Abstract]   [Full Text] [Related]  

  • 2. Malakoplakia in a patient with complicated urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli.
    Lee WS; Chen WY; Ou TY; Chen FL; Lin YW
    J Microbiol Immunol Infect; 2015 Jun; 48(3):345-6. PubMed ID: 24530255
    [No Abstract]   [Full Text] [Related]  

  • 3. High prevalence of ESBL-producing Escherichia coli isolates among hemodialysis patients in Portugal: appearance of ST410 with the bla(CTX-M-14) gene.
    Correia S; Pacheco R; Radhouani H; Diniz JC; Ponce P; Jones-Dias D; Caniça M; Igrejas G; Poeta P
    Diagn Microbiol Infect Dis; 2012 Dec; 74(4):423-5. PubMed ID: 23000286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of extended-spectrum β-lactamase-producing Escherichia coli in catheter-associated urinary tract infection in neurogenic bladder patients.
    Takaba K; Shigemura K; Osawa K; Nomi M; Fujisawa M; Arakawa S
    Am J Infect Control; 2014 Mar; 42(3):e29-31. PubMed ID: 24581025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Ena J; Arjona F; Martínez-Peinado C; López-Perezagua Mdel M; Amador C
    Urology; 2006 Dec; 68(6):1169-74. PubMed ID: 17169640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First detection of VIM-4 metallo-β-lactamase-producing Escherichia coli in Russia.
    Shevchenko OV; Mudrak DY; Skleenova EY; Kozyreva VK; Ilina EN; Ikryannikova LN; Alexandrova IA; Sidorenko SV; Edelstein MV
    Clin Microbiol Infect; 2012 Jul; 18(7):E214-7. PubMed ID: 22487052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal dissemination of highly virulent extended-spectrum beta-lactamase-producing Escherichia coli strains isolated from the urine of non-hospitalised patients in Zagreb region.
    Vranes J; Marijan T; Bedenic B; Mlinaric-Dzepina A; Katic S; Kalenic S
    Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S19-24. PubMed ID: 17936594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children.
    Fan NC; Chen HH; Chen CL; Ou LS; Lin TY; Tsai MH; Chiu CH
    J Microbiol Immunol Infect; 2014 Oct; 47(5):399-405. PubMed ID: 23834784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and characterization of extended-spectrum β-lactamase- and AmpC β-lactamase-producing Escherichia coli: results of the CANWARD 2007-2009 study.
    Simner PJ; Zhanel GG; Pitout J; Tailor F; McCracken M; Mulvey MR; Lagacé-Wiens PR; Adam HJ; Hoban DJ;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):326-34. PubMed ID: 21353961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and types of extended spectrum β-lactamases among urinary Escherichia coli isolates in Moroccan community.
    Barguigua A; El Otmani F; Talmi M; Zerouali K; Timinouni M
    Microb Pathog; 2013; 61-62():16-22. PubMed ID: 23643553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escherichia coli ST131 producing extended-spectrum β-lactamases plus VIM-1 carbapenemase: further narrowing of treatment options.
    Mantengoli E; Luzzaro F; Pecile P; Cecconi D; Cavallo A; Attala L; Bartoloni A; Rossolini GM
    Clin Infect Dis; 2011 Mar; 52(5):690-1. PubMed ID: 21220769
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenotypes of Escherichia coli isolated from urine: Differences between extended-spectrum β-lactamase producers and sensitive strains.
    Šišková P; Černohorská L; Mahelová M; Turková K; Woznicová V
    J Microbiol Immunol Infect; 2015 Jun; 48(3):329-34. PubMed ID: 24865414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
    Mendonça N; Leitão J; Manageiro V; Ferreira E; Caniça M
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1946-55. PubMed ID: 17371815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
    Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
    N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of a multiresistant KPC-3 and VIM-1 carbapenemase-producing Escherichia coli strain in Spain.
    Porres-Osante N; Azcona-Gutiérrez JM; Rojo-Bezares B; Undabeitia E; Torres C; Sáenz Y
    J Antimicrob Chemother; 2014 Jul; 69(7):1792-5. PubMed ID: 24583362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Increasing prevalence of fosfomycin resistance in extended-spectrum-beta-lactamase-producing Escherichia coli urinary isolates (2005-2009-2011)].
    Rodríguez-Avial C; Rodríguez-Avial I; Hernández E; Picazo JJ
    Rev Esp Quimioter; 2013 Mar; 26(1):43-6. PubMed ID: 23546462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of multidrug resistance to oral antibiotics among Escherichia coli urine isolates from outpatient departments in Germany: extended-spectrum β-lactamases and the role of fosfomycin.
    Kresken M; Pfeifer Y; Hafner D; Wresch R; Körber-Irrgang B;
    Int J Antimicrob Agents; 2014 Oct; 44(4):295-300. PubMed ID: 25223936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-beta-lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate.
    Lagacé-Wiens PR; Nichol KA; Nicolle LE; DeCorby M; McCracken M; Mulvey MR; Zhanel GG
    J Antimicrob Chemother; 2006 Jun; 57(6):1262-3. PubMed ID: 16565157
    [No Abstract]   [Full Text] [Related]  

  • 19. High percentage of resistance to ciprofloxacin and qnrB19 gene identified in urinary isolates of extended-spectrum beta-lactamase-producing Escherichia coli in Madrid, Spain.
    Ríos E; Rodríguez-Avial I; Rodríguez-Avial C; Hernandez E; Picazo JJ
    Diagn Microbiol Infect Dis; 2010 Aug; 67(4):380-3. PubMed ID: 20638608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are beta-lactams related to higher morbidity and mortality in urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli?
    You JH; Kei HW; Lau WC; Wong KY; Marasinghe T; Lee N; Ip M
    J Hosp Infect; 2008 Feb; 68(2):181-3. PubMed ID: 18194826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.